BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23402904)

  • 21. Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer.
    Paek J; Lee SH; Yim GW; Lee M; Kim YJ; Nam EJ; Kim SW; Kim YT
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):338-42. PubMed ID: 21683503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery.
    Ataseven B; du Bois A; Reinthaller A; Traut A; Heitz F; Aust S; Prader S; Polterauer S; Harter P; Grimm C
    Gynecol Oncol; 2015 Sep; 138(3):560-5. PubMed ID: 26163893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of adiponectin and leptin in the treatment of ovarian cancer patients.
    Słomian GJ; Nowak D; Buczkowska M; Głogowska-Gruszka A; Słomian SP; Roczniak W; Janyga S; Nowak P
    Endokrynol Pol; 2019; 70(1):57-63. PubMed ID: 30450532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Adiponectin Receptor-1 and Prognosis of Epithelial Ovarian Cancer Patients.
    Li X; Yu Z; Fang L; Liu F; Jiang K
    Med Sci Monit; 2017 Mar; 23():1514-1521. PubMed ID: 28356549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer.
    Paek J; Lee M; Nam EJ; Kim SW; Kim YT
    Arch Gynecol Obstet; 2016 Mar; 293(3):645-50. PubMed ID: 26305032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in epithelial ovarian cancer: A population-based study.
    Chang LC; Huang CF; Lai MS; Shen LJ; Wu FL; Cheng WF
    PLoS One; 2018; 13(3):e0194993. PubMed ID: 29579127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes.
    Skaznik-Wikiel ME; Lesnock JL; McBee WC; Beriwal S; Zorn KK; Richard SD; Krivak TC; Edwards RP
    Int J Gynecol Cancer; 2012 Feb; 22(2):232-7. PubMed ID: 22080886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer.
    Paik ES; Sohn I; Baek SY; Shim M; Choi HJ; Kim TJ; Choi CH; Lee JW; Kim BG; Lee YY; Bae DS
    Cancer Res Treat; 2017 Jul; 49(3):635-642. PubMed ID: 27669704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
    Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature.
    Blake EA; Kodama M; Yunokawa M; Ross MS; Ueda Y; Grubbs BH; Matsuo K
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():97-105. PubMed ID: 25668134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
    Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
    J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study.
    So KA; Hong JH; Jin HM; Kim JW; Song JY; Lee JK; Lee NW
    Gynecol Oncol; 2014 Mar; 132(3):551-5. PubMed ID: 24440470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer.
    Tas F; Kilic L; Bilgin E; Keskin S; Sen F; Ciftci R; Yildiz I; Yasasever V
    Int J Gynecol Cancer; 2013 Feb; 23(2):276-81. PubMed ID: 23266651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
    Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
    Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective.
    Elstrand MB; Sandstad B; Oksefjell H; Davidson B; Tropé CG
    Acta Obstet Gynecol Scand; 2012 Mar; 91(3):308-17. PubMed ID: 22050605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands.
    van Altena AM; Karim-Kos HE; de Vries E; Kruitwagen RF; Massuger LF; Kiemeney LA
    Gynecol Oncol; 2012 Jun; 125(3):649-54. PubMed ID: 22370602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A quantitative deficiency in peripheral blood Vγ9Vδ2 cells is a negative prognostic biomarker in ovarian cancer patients.
    Thedrez A; Lavoué V; Dessarthe B; Daniel P; Henno S; Jaffre I; Levêque J; Catros V; Cabillic F
    PLoS One; 2013; 8(5):e63322. PubMed ID: 23717410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: a multicenter study.
    Ferrero A; Ditto A; Giorda G; Gadducci A; Greggi S; Daniele A; Fuso L; Panuccio E; Scaffa C; Raspagliesi F; Sismondi P; Biglia N
    Eur J Surg Oncol; 2014 Jul; 40(7):891-8. PubMed ID: 24378007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The survival detriment of venous thromboembolism with epithelial ovarian cancer.
    Gunderson CC; Thomas ED; Slaughter KN; Farrell R; Ding K; Farris RE; Lauer JK; Perry LJ; McMeekin DS; Moore KN
    Gynecol Oncol; 2014 Jul; 134(1):73-7. PubMed ID: 24793732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.